Published in Mol Clin Oncol on March 10, 2016
Resistin potentiates chemoresistance and stemness of breast cancer cells: Implications for racially disparate therapeutic outcomes. Cancer Lett (2017) 0.75
Resistin confers resistance to doxorubicin-induced apoptosis in human breast cancer cells through autophagy induction. Am J Cancer Res (2017) 0.75
Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia (1985) 109.13
The hormone resistin links obesity to diabetes. Nature (2001) 15.49
Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science (2001) 7.13
The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab (2003) 4.55
Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. J Natl Cancer Inst (2008) 3.73
A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis. Int J Radiat Oncol Biol Phys (1995) 3.53
Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol (2001) 3.23
Nutrition, hormones, and breast cancer: is insulin the missing link? Cancer Causes Control (1996) 2.55
Stress and radiation-induced activation of multiple intracellular signaling pathways. Radiat Res (2003) 2.49
Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Cancer Lett (2005) 2.13
Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer. Obes Rev (2007) 1.99
Circulating insulin and c-peptide levels and risk of breast cancer among predominately premenopausal women. Cancer Epidemiol Biomarkers Prev (2007) 1.95
Serum insulin and glucose levels and breast cancer incidence: the atherosclerosis risk in communities study. Am J Epidemiol (2002) 1.91
Circulating levels of leptin, adiposity and breast cancer risk. Br J Cancer (2009) 1.78
Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice. Cancer Res (2006) 1.75
Radiation pneumonitis and early circulatory cytokine markers. Semin Radiat Oncol (2002) 1.62
Leptin expression in colorectal and breast cancer patients. Int J Mol Med (2000) 1.58
The role of resistin as a regulator of inflammation: Implications for various human pathologies. Clin Immunol (2009) 1.58
Mitogenic properties of insulin and insulin analogues mediated by the insulin receptor. Diabetologia (1997) 1.45
Predicting the risk of symptomatic radiation-induced lung injury using both the physical and biologic parameters V(30) and transforming growth factor beta. Int J Radiat Oncol Biol Phys (2001) 1.38
Molecular mechanisms of leptin and adiponectin in breast cancer. Eur J Cancer (2011) 1.36
Repeated measures of serum glucose and insulin in relation to postmenopausal breast cancer. Int J Cancer (2009) 1.34
Upper abdominal obesity, insulin resistance and breast cancer risk. Int J Obes Relat Metab Disord (2002) 1.19
Relationship of serum adiponectin and resistin levels with breast cancer risk. J Korean Med Sci (2007) 1.19
Effect of insulin on cell cycle progression in MCF-7 breast cancer cells. Direct and potentiating influence. J Biol Chem (2001) 1.14
Role of hormones in the growth and regression of human breast cancer cells (MCF-7) transplanted into athymic nude mice. J Natl Cancer Inst (1981) 1.13
Adipose tissue as target organ in the treatment of hormone-dependent breast cancer: new therapeutic perspectives. Obes Rev (2009) 1.06
Serum resistin: a biomarker of breast cancer in postmenopausal women? Association with clinicopathological characteristics, tumor markers, inflammatory and metabolic parameters. Clin Biochem (2013) 0.94
Visfatin stimulates proliferation of MCF-7 human breast cancer cells. Mol Cells (2010) 0.94
Metabolic syndrome and the menopause. Menopause Int (2008) 0.92
Circulating thrombomodulin during radiation therapy of lung cancer. Radiat Oncol Investig (1999) 0.91
Proliferation kinetics of x-irradiated mouse L cells studied WITH TIME-lapse photography. II. Int J Radiat Biol Relat Stud Phys Chem Med (1969) 0.90
Could serum visfatin be a potential biomarker for postmenopausal breast cancer? Maturitas (2012) 0.88
Insulin receptor levels and magnitude of insulin-induced responses in 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats. Cancer Res (1981) 0.82
The development of the metabolic syndrome and insulin resistance after adjuvant treatment for breast cancer. Cancer Nurs (2014) 0.82
Adipocytokine levels of colon cancer patients before and after treatment. Bratisl Lek Listy (2013) 0.80